Catalyst Wire Dossier Catalyst Wire Dossier

VRC01 antibody

VRC01 · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC01 antibody, covering 2018-10-17 to 2018-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection [Phase 2]

See pricing